Squarepoint’s Organon & Co OGN Stock Holding History

Squarepoint’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-87,400	Closed	-$524K	–	4812
2026 Q1	$524K	Buy	+87,400	New	+$658K	﹤0.01%	3307

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Squarepoint's OGN Position: Q2 2026 in Review

Squarepoint reduced its Organon & Co (OGN) stake by 53% in Q2 2026, selling an estimated $5.28M and leaving 390,232 shares worth $5.28M. The position accounts for 0.01% of the portfolio, ranked #1562.

Squarepoint first reported a position in OGN in Q2 2021 and has held it in 19 quarters since. The position peaked at $20.8M in Q4 2023. 636 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Squarepoint held 390,232 shares of Organon & Co worth $5.28M as of Q2 2026.
Squarepoint sold 441,192 Organon & Co shares in Q2 2026, an estimated $5.28M.
Organon & Co made up 0.01% of Squarepoint's portfolio in Q2 2026, its #1562 holding.
Squarepoint first reported a position in Organon & Co in Q2 2021 and has held it in 19 quarters since.
Squarepoint's Organon & Co position peaked at $20.8M in Q4 2023.
636 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.